Europe Cold Sore Treatment Market is expected to grow at 5.9 % In the Forecast Period of 2021 to 2028

Cold Sore Treatment Market is growing with factors such as increased prevalence of cold sore infection, spread in modes of transmission of herpes simplex virus, increased consciousness about sexually transmitted diseases (STDs), availability of generic drugs and rise in cases of HSV in women.

However, the patent expiry of marketed drugs and risks of other diseases associated with cold sore may obstruct the growth of the market in the given forecast period.

Europe Cold Sore Treatment Market Scenario                        

According to Data Bridge Market Research, the market for Cold Sore Treatment in Europe region has the highest market share. Market leader is GlaxoSmithKline plc which accounts an estimated market share of approximately 21.46%. The company has gained outstanding sale through providing generic drugs associated with cold sore to all the countries and rapid product approvals.

  • In December 2020, GlaxoSmithKline plc and Sanofi Inc had declared the delay in the adjuvant recombinant protein based COVID-19 vaccine programme to enhance immune response in the elderly population. This initiative by both the companies would result in delay of the cold sore treatment products, less revenue and less growth in the market.

 Europe Cold Sore Treatment MarketTrends Impacting the Market

Now the question is which other regions is GlaxoSmithKline plc, Novartis AG, and Hikima Pharmaceuticals PLC are targeting? Data Bridge Market Research has estimated a large growth in Europe Cold Sore Treatment market and the market leaders targeting Germany, U.K. and France to be their next revenue pockets for 2021.

The cold sore treatment market is becoming more competitive with companies such as GlaxoSmithKline plc, GlaxoSmithKline plc, Novartis AG, and Hikima Pharmaceuticals PLC as they are the market leaders for paint protection film market. The data bridge market research new reports highlight the major growth factors and opportunities in the Paint Protection Film market.

For more analysis on the Europe Cold Sore Treatment market request for a briefing with our analysts

Europe Cold Sore Treatment Market Development

  • In May 2020, Teva Pharmaceutical Industries Ltd. reported that the 2020 annual meeting of shareholders will be held online by looking at the COVID-19 scenario and in the interest of health and safety of its shareholders, directors, officers and employees. This will help in creating and discussing strategies for the coming year.

Scope of the Europe Cold Sore Treatment Market.

Europe Cold Sore Treatment Market is segmented on the basis of countries Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, and rest of Europe.

All country based analysis of Europe cold sores treatment market is further analyzed based on further segmentation. On the basis of strain type, the market is segmented into herpes simplex type-1 virus, and herpes simplex type-2 virus. On the basis of therapeutics, the market is segmented into Antiviral agents, Analgesic agents, and others. On the basis of drug use the market is segmented into branded and generics. On the basis of dosage type the market is segmented into oral, topical, and others. On the basis of end user, the market is segmented into hospitals, home care, specialty clinics, and others. On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

To know more about the study

Key Pointers Covered in Europe Cold Sore Treatment Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • GlaxoSmithKline plc
  • Amneal Pharmaceuticals LLC
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Pharmaceuticals, Inc. (A Subsidiary of Zydus Cadila)
  • Cipla Inc.
  • AiCuris
  • Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
  • Aurobindo Pharma U.S.A.  (A Subsidiary of Aurobindo Pharma)
  • Novartis AG
  • Hikma Pharmaceuticals PLC
  • Hetero Healthcare Limited
  • Apotex Inc.
  • HRA Pharma

Above are the key players covered in the report, to know about more and exhaustive list of cold sore treatment market companies’, contact us

Research Methodology: Europe Cold Sore Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

  • Primary Respondents
  • Demand Side: Chief Level Officers, Product and Marketing Manager, Distributors, Buyers.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports


Browse in Healthcare Category Related Reports@